Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
Plos One
|
December 7, 2013
Monoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1
Peter M Zygmunt, Anna Ermund, Pouya Movahed, et al.
Progress in Neurobiology
|
June 9, 2020
mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment
Pierre-Yves Martin, Stéphane Doly, Al Mahdy Hamieh, et al.
The EMBO Journal
|
May 6, 2006
TREK-1, a K+ channel involved in polymodal pain perception
Abdelkrim Alloui, Katharina Zimmermann, Julien Mamet, et al.
JMIR Mhealth and Uhealth
|
June 12, 2024
Mobile Health App and Web Platform (eDOL) for Medical Follow-Up of Patients With Chronic Pain: Cohort Study Involving the French eDOL National Cohort After 1 Year
Noémie Delage, Nathalie Cantagrel, Sandrine Soriot-Thomas, et al.
Cell Reports
|
May 12, 2015
The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia
Stéphane Lolignier, Caroline Bonnet, Christelle Gaudioso, et al.
Neuropharmacology
|
July 30, 2018
Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin
Laura Poupon, Sylvain Lamoine, Vanessa Pereira, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 12, 2020
Testosterone-androgen receptor: The steroid link inhibiting TRPM8-mediated cold sensitivity
Dimitra Gkika, Stéphane Lolignier, Guillaume P Grolez, et al.
Archives of Cardiovascular Diseases
|
April 25, 2016
Prognosis and management of myocardial infarction: Comparisons between the French FAST-MI 2010 registry and the French public health database
Grégoire Massoullié, Jérome Wintzer-Wehekind, Chouki Chenaf, et al.
British Journal of Pharmacology
|
August 28, 2020
TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects
Jérôme Busserolles, Ismail Ben Soussia, Laetitia Pouchol, et al.
International Journal of Molecular Sciences
|
January 11, 2022
The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice
Sylvain Lamoine, Mélissa Cumenal, David A Barriere, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
Plos One
|
December 7, 2013
Monoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1
Peter M Zygmunt, Anna Ermund, Pouya Movahed, et al.
Progress in Neurobiology
|
June 9, 2020
mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment
Pierre-Yves Martin, Stéphane Doly, Al Mahdy Hamieh, et al.
The EMBO Journal
|
May 6, 2006
TREK-1, a K+ channel involved in polymodal pain perception
Abdelkrim Alloui, Katharina Zimmermann, Julien Mamet, et al.
JMIR Mhealth and Uhealth
|
June 12, 2024
Mobile Health App and Web Platform (eDOL) for Medical Follow-Up of Patients With Chronic Pain: Cohort Study Involving the French eDOL National Cohort After 1 Year
Noémie Delage, Nathalie Cantagrel, Sandrine Soriot-Thomas, et al.
Cell Reports
|
May 12, 2015
The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia
Stéphane Lolignier, Caroline Bonnet, Christelle Gaudioso, et al.
Neuropharmacology
|
July 30, 2018
Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin
Laura Poupon, Sylvain Lamoine, Vanessa Pereira, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 12, 2020
Testosterone-androgen receptor: The steroid link inhibiting TRPM8-mediated cold sensitivity
Dimitra Gkika, Stéphane Lolignier, Guillaume P Grolez, et al.
Archives of Cardiovascular Diseases
|
April 25, 2016
Prognosis and management of myocardial infarction: Comparisons between the French FAST-MI 2010 registry and the French public health database
Grégoire Massoullié, Jérome Wintzer-Wehekind, Chouki Chenaf, et al.
British Journal of Pharmacology
|
August 28, 2020
TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects
Jérôme Busserolles, Ismail Ben Soussia, Laetitia Pouchol, et al.
International Journal of Molecular Sciences
|
January 11, 2022
The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice
Sylvain Lamoine, Mélissa Cumenal, David A Barriere, et al.
Page
of 15